Načítá se...
Power/Sample Size Calculations for Assessing Correlates of Risk in Clinical Efficacy Trials
In a randomized controlled clinical trial that assesses treatment efficacy, a common objective is to assess the association of a measured biomarker response endpoint with the primary study endpoint in the active treatment group, using a case-cohort, case-control, or two-phase sampling design. Method...
Uloženo v:
| Vydáno v: | Stat Med |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965346/ https://ncbi.nlm.nih.gov/pubmed/27037797 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/sim.6952 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|